Di Bella's therapy: the last word?

BMJ 1999; 318 doi: http://dx.doi.org/10.1136/bmj.318.7178.208 (Published 23 January 1999)
Cite this as: BMJ 1999;318:208

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

The evidence would be stronger if the researchers had randomised their studies

  1. Marcus MÜllner, Editorial registrar.
  1. BMJ

    Papers p 224 and Reviews p 268

    Wonder cures for cancer appear regularly. The latest comes from Italian physiologist Luigi Di Bella, whose “multitherapy” comprises a mixture of melatonin, bromocriptine, somatostatin, a solution of retinoids, and, depending on the kind of cancer, either cyclophosphamide or hydroxyurea. Political and media support for Di Bella's treatment led to the courts ruling that Italian hospitals must provide it.1 But research that we publish today (p 224),2 which has already been reported in the media, suggests that the treatment is ineffective and toxic. The research could, however, have been better designed.

    The researchers, who were funded by the Italian government, conducted 11independent uncontrolled multicentre trials …

    Get access to this article and all of bmj.com for the next 14 days

    Sign up for a 14 day free trial today

    Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL